PTC THERAPEUTICS, INC. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PTC THERAPEUTICS, INC. for September 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,001 | 32,561 | 146,999 | |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 4,099 | 44,474 | 10,001 | |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 900 | 9,765 | 14,100 | |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 46.90 | 3,000 | 140,700 | 9,000 | 12 K to 9 K (-25.00 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 44.92 | 3,000 | 134,760 | 12,000 | 15 K to 12 K (-20.00 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 44.15 | 7,100 | 313,465 | 15,000 | 22.1 K to 15 K (-32.13 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,001 | 32,561 | 22,100 | 19.1 K to 22.1 K (+15.71 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 4,099 | 44,474 | 19,099 | 15 K to 19.1 K (+27.33 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 42.88 | 2,000 | 85,760 | 15,000 | 17 K to 15 K (-11.76 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 43.86 | 900 | 39,474 | 17,000 | 17.9 K to 17 K (-5.03 %) |
Sep 26 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 900 | 9,765 | 17,900 | 17 K to 17.9 K (+5.29 %) |
Sep 22 2014 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Sell | S | 40.16 | 2,000 | 80,320 | 28,464 | 30.5 K to 28.5 K (-6.57 %) |
Sep 16 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 36.41 | 1,840 | 66,994 | 17,000 | 18.8 K to 17 K (-9.77 %) |
Sep 16 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 35.72 | 3,160 | 112,875 | 18,840 | 22 K to 18.8 K (-14.36 %) |
Sep 16 2014 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Sell | S | 36.68 | 3,000 | 110,040 | 22,000 | 25 K to 22 K (-12.00 %) |
Sep 11 2014 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 849 | 0 | 1,130,291 | 1.1 M to 1.1 M (-0.08 %) |
Sep 11 2014 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Sell | J | 0.00 | 1,125,742 | 0 | 1,131,140 | 2.3 M to 1.1 M (-49.88 %) |
Sep 08 2014 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Buy | P | 24.50 | 23,000 | 563,500 | 1,320,369 | 1.3 M to 1.3 M (+1.77 %) |